Laura A. Linynsky - May 9, 2024 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role
Director
Signature
/s/ Mary Ann E. Moore, Attorney-in-Fact
Stock symbol
MD
Transactions as of
May 9, 2024
Transactions value $
$0
Form type
4
Date filed
5/13/2024, 05:00 PM
Previous filing
May 15, 2023
Next filing
Aug 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Award $0 +18.4K +94.42% $0.00 37.8K May 9, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Restricted shares granted pursupant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 9, 2025.